This protocol is judged by an institutional overview board, an independent team that assessments any scientific trials involving humans. If a analyze entails a Agenda I drug, when the board approves the protocol as moral, the researchers must apply for an investigational new drug (IND) number from the FDA.While using the doses packaged and labelled